Delivering mitochondrial health
In late November, Abliva will participate in BioStock's Life Science Summit in Lund, Sweden. CMO, Magnus Hansson, will be presenting the company at 15:10 CET on November 21. For more details on the event, follow the link below.
In mid-November, Abliva will attend LSX's Investival Showcase in London, UK. Abliva's CEO, Ellen Donnelly, will be presenting the company at 11:30 a.m. GMT. The Investival Showcase is a Biotech, Healthtech, and Medtech Networking & Pitching Event. Follow the link below for more details.
Abliva will attend the CNS Summit 2024, taking place November 10-13 at Encore Boston Harbor. The company's CEO, Ellen Donnelly, has organized and will join the spotlight panel discussion: Medicines for Mito: Developing Medicines for Mitochondrial Dysfunction Spotlight Session, on November 11, at 1:00 p.m. ET, featuring representatives from Stealth-, Tisento- and Saol Therapeutics. Follow […]
